Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| MERIT MEDICAL SYSTEMS INCMMSI · Entity 3858 | Director | May 27, 2020 | May 29, 2020 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
MERIT MEDICAL SYSTEMS INC
Report date May 27, 2020 · Filed May 29, 2020
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock, No Par ValueSEC Table I · non-derivative | Direct | 10,500 |
Ending reported balance
After 2020-05-28 transaction · row 4
4 source rows · reconciled sequenceRow 1 · 2020-05-27 · Exercise / conversion · Acquired 5,000 · Balance 15,500 Row 2 · 2020-05-27 · Sale · Disposed 5,000 · Balance 10,500 F1: The price reported in Column 4 of Table 1 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $43.75 to $44.49, inclusive. The Reporting Person undertakes to provide to Merit Medical Systems, Inc., any security holder of Merit Medical Systems, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Row 3 · 2020-05-28 · Exercise / conversion · Acquired 5,000 · Balance 15,500 Row 4 · 2020-05-28 · Sale · Disposed 5,000 · Balance 10,500 F2: The price reported in Column 4 of Table 1 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $43.46 to $44.40, inclusive. The Reporting Person undertakes to provide to Merit Medical Systems, Inc., any security holder of Merit Medical Systems, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. |
| Non-qualified stock options (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $13.99 · Expires 2021-06-11 | Direct | 20,000 |
Reported balance
After 2020-05-27 transaction · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · 2020-05-27 · Exercise / conversion · Disposed 5,000 · Balance 20,000 F3: Becomes exercisable in equal annual installments of 20% commencing 06/11/2015. |
| Non-qualified stock options (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $13.99 · Expires 2021-06-11 | Direct | 15,000 |
Reported balance
After 2020-05-28 transaction · row 8
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 8 · 2020-05-28 · Exercise / conversion · Disposed 5,000 · Balance 15,000 F3: Becomes exercisable in equal annual installments of 20% commencing 06/11/2015. |
| Non-qualified stock options (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $20.27 · Expires 2022-05-22 | Direct | 25,000 |
Reported balance
Holding disclosure · report date 2020-05-27 · row 9
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 9 · Balance 25,000 F4: Becomes exercisable in equal annual installments of 20% commencing 05/22/2016. |
| Non-qualified stock options (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $18.80 · Expires 2023-05-26 | Direct | 25,000 |
Reported balance
Holding disclosure · report date 2020-05-27 · row 10
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 10 · Balance 25,000 F5: Becomes exercisable in equal annual installments of 20% commencing 05/26/2017. |
| Non-qualified stock options (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $34.40 · Expires 2024-05-24 | Direct | 25,000 |
Reported balance
Holding disclosure · report date 2020-05-27 · row 11
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 11 · Balance 25,000 F6: Becomes exercisable in equal annual installments of 20% commencing 05/24/2018. |
| Non-qualified stock options (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $50.50 · Expires 2025-06-07 | Direct | 25,000 |
Reported balance
Holding disclosure · report date 2020-05-27 · row 12
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 12 · Balance 25,000 F7: Becomes exercisable in equal annual installments of 20% commencing 06/07/2019. |
| Non-qualified stock options (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $52.17 · Expires 2026-05-24 | Direct | 13,750 |
Reported balance
Holding disclosure · report date 2020-05-27 · row 13
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 13 · Balance 13,750 F8: Becomes exercisable in equal annual installments of 33% commencing 05/24/2020. |
| Non-qualified stock options (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $52.17 · Expires 2026-05-31 | Direct | 7,500 |
Reported balance
Holding disclosure · report date 2020-05-27 · row 14
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 14 · Balance 7,500 F9: Becomes exercisable in equal annual installments of 33% commencing 05/31/2020. |
| Common Stock, No Par ValueSEC Table I · non-derivative | IndirectBy IRA | 4,000 |
Reported balance
Holding disclosure · report date 2020-05-27 · row 5
Holding and transaction disclosures are not merged.
1 source rowRow 5 · Balance 4,000 |
| Common Stock, No Par ValueSEC Table I · non-derivative | IndirectTrustee for Revocable Trust | 2,000 |
Reported balance
Holding disclosure · report date 2020-05-27 · row 6
Holding and transaction disclosures are not merged.
1 source rowRow 6 · Balance 2,000 |
Filing footnotes · ownership attribution and instrument terms
F1: The price reported in Column 4 of Table 1 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $43.75 to $44.49, inclusive. The Reporting Person undertakes to provide to Merit Medical Systems, Inc., any security holder of Merit Medical Systems, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
F2: The price reported in Column 4 of Table 1 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $43.46 to $44.40, inclusive. The Reporting Person undertakes to provide to Merit Medical Systems, Inc., any security holder of Merit Medical Systems, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
F3: Becomes exercisable in equal annual installments of 20% commencing 06/11/2015.
F4: Becomes exercisable in equal annual installments of 20% commencing 05/22/2016.
F5: Becomes exercisable in equal annual installments of 20% commencing 05/26/2017.
F6: Becomes exercisable in equal annual installments of 20% commencing 05/24/2018.
F7: Becomes exercisable in equal annual installments of 20% commencing 06/07/2019.
F8: Becomes exercisable in equal annual installments of 33% commencing 05/24/2020.
F9: Becomes exercisable in equal annual installments of 33% commencing 05/31/2020.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 28, 2020 Filed May 29, 2020 19:46 UTC | MERIT MEDICAL SYSTEMS INC MMSI · Entity 3858 | Exercise / conversionNon-qualified stock options (right to buy) · Derivative | 5,000 | $0.00 Strike: $13.99 | $0.00 |
DisclosureSEC source: 0001415889-20-001371 · form4-05292020_120544.xml · derivative · entry 8 Karras Nolan E. · CIK 0001534914 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Underlying: Common Stock · 5,000 shares Expires 2021-06-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Becomes exercisable in equal annual installments of 20% commencing 06/11/2015. Read SEC document |
| May 28, 2020 Filed May 29, 2020 19:46 UTC | MERIT MEDICAL SYSTEMS INC MMSI · Entity 3858 | SaleCommon Stock, No Par Value | 5,000 | $43.87 | $219,350.00 |
DisclosureSEC source: 0001415889-20-001371 · form4-05292020_120544.xml · nonDerivative · entry 4 Karras Nolan E. · CIK 0001534914 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,500 F2 · price: The price reported in Column 4 of Table 1 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $43.46 to $44.40, inclusive. The Reporting Person undertakes to provide to Merit Medical Systems, Inc., any security holder of Merit Medical Systems, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Read SEC document |
| May 28, 2020 Filed May 29, 2020 19:46 UTC | MERIT MEDICAL SYSTEMS INC MMSI · Entity 3858 | Exercise / conversionCommon Stock, No Par Value | 5,000 | $13.99 | $69,950.00 |
DisclosureSEC source: 0001415889-20-001371 · form4-05292020_120544.xml · nonDerivative · entry 3 Karras Nolan E. · CIK 0001534914 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,500 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 27, 2020 Filed May 29, 2020 19:46 UTC | MERIT MEDICAL SYSTEMS INC MMSI · Entity 3858 | Exercise / conversionNon-qualified stock options (right to buy) · Derivative | 5,000 | $0.00 Strike: $13.99 | $0.00 |
DisclosureSEC source: 0001415889-20-001371 · form4-05292020_120544.xml · derivative · entry 7 Karras Nolan E. · CIK 0001534914 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 5,000 shares Expires 2021-06-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Becomes exercisable in equal annual installments of 20% commencing 06/11/2015. Read SEC document |
| May 27, 2020 Filed May 29, 2020 19:46 UTC | MERIT MEDICAL SYSTEMS INC MMSI · Entity 3858 | SaleCommon Stock, No Par Value | 5,000 | $44.12 | $220,600.00 |
DisclosureSEC source: 0001415889-20-001371 · form4-05292020_120544.xml · nonDerivative · entry 2 Karras Nolan E. · CIK 0001534914 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,500 F1 · price: The price reported in Column 4 of Table 1 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $43.75 to $44.49, inclusive. The Reporting Person undertakes to provide to Merit Medical Systems, Inc., any security holder of Merit Medical Systems, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Read SEC document |
| May 27, 2020 Filed May 29, 2020 19:46 UTC | MERIT MEDICAL SYSTEMS INC MMSI · Entity 3858 | Exercise / conversionCommon Stock, No Par Value | 5,000 | $13.99 | $69,950.00 |
DisclosureSEC source: 0001415889-20-001371 · form4-05292020_120544.xml · nonDerivative · entry 1 Karras Nolan E. · CIK 0001534914 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,500 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 02, 2020 Filed Mar 3, 2020 22:26 UTC | MERIT MEDICAL SYSTEMS INC MMSI · Entity 3858 | Exercise / conversionNon-qualified stock options (right to buy) · Derivative | 8,000 | $0.00 Strike: $9.95 | $0.00 |
DisclosureSEC source: 0001104659-20-028705 · a4.xml · derivative · entry 5 Karras Nolan E. · CIK 0001534914 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 0 shares Expires 2020-05-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Becomes exercisable in equal annual installments of 20% commencing 05/22/2014. Read SEC document |
| March 02, 2020 Filed Mar 3, 2020 22:26 UTC | MERIT MEDICAL SYSTEMS INC MMSI · Entity 3858 | SaleCommon Stock, No Par Value | 5,500 | $36.69 | $201,795.00 |
DisclosureSEC source: 0001104659-20-028705 · a4.xml · nonDerivative · entry 4 Karras Nolan E. · CIK 0001534914 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,500 F1 · price: The price reported in Column 4 of Table 1 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.48 to $36.98, inclusive. The Reporting Person undertakes to provide to Merit Medical Systems, Inc., any security holder of Merit Medical Systems, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Read SEC document |
| March 02, 2020 Filed Mar 3, 2020 22:26 UTC | MERIT MEDICAL SYSTEMS INC MMSI · Entity 3858 | Exercise / conversionCommon Stock, No Par Value | 8,000 | $9.95 | $79,600.00 |
DisclosureSEC source: 0001104659-20-028705 · a4.xml · nonDerivative · entry 3 Karras Nolan E. · CIK 0001534914 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 16, 2019 Filed Aug 20, 2019 23:22 UTC | MERIT MEDICAL SYSTEMS INC MMSI · Entity 3858 | Exercise / conversionNon-qualified stock options (right to buy) · Derivative | 8,000 | $0.00 Strike: $9.95 | $0.00 |
DisclosureSEC source: 0000856982-19-000117 · wf-form4_156634331321655.xml · derivative · entry 5 Karras Nolan E. · CIK 0001534914 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,000 Underlying: Common Stock · 8,000 shares Expires 2020-05-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Becomes exercisable in equal annual installments of 20% commencing 05/22/2014. Read SEC document |
| August 16, 2019 Filed Aug 20, 2019 23:22 UTC | MERIT MEDICAL SYSTEMS INC MMSI · Entity 3858 | SaleCommon Stock, No Par Value | 4,000 | $36.46 | $145,840.00 |
DisclosureSEC source: 0000856982-19-000117 · wf-form4_156634331321655.xml · nonDerivative · entry 4 Karras Nolan E. · CIK 0001534914 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,000 F1 · price: The price reported in Column 4 of Table 1 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.440 to $36.565, inclusive. The Reporting Person undertakes to provide to Merit Medical Systems, Inc., any security holder of Merit Medical Systems, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Read SEC document |
| August 16, 2019 Filed Aug 20, 2019 23:22 UTC | MERIT MEDICAL SYSTEMS INC MMSI · Entity 3858 | Exercise / conversionCommon Stock, No Par Value | 8,000 | $9.95 | $79,600.00 |
DisclosureSEC source: 0000856982-19-000117 · wf-form4_156634331321655.xml · nonDerivative · entry 3 Karras Nolan E. · CIK 0001534914 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 19, 2019 Filed Jun 20, 2019 22:22 UTC | MERIT MEDICAL SYSTEMS INC MMSI · Entity 3858 | Exercise / conversionNon-qualified stock options (right to buy) · Derivative | 6,000 | $0.00 Strike: $9.95 | $0.00 |
DisclosureSEC source: 0000856982-19-000095 · wf-form4_156106935965019.xml · derivative · entry 5 Karras Nolan E. · CIK 0001534914 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,000 Underlying: Common Stock · 6,000 shares Expires 2020-05-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Becomes exercisable in equal annual installments of 20% commencing 05/22/2014. Read SEC document |
| June 19, 2019 Filed Jun 20, 2019 22:22 UTC | MERIT MEDICAL SYSTEMS INC MMSI · Entity 3858 | SaleCommon Stock, No Par Value | 4,000 | $60.91 | $243,640.00 |
DisclosureSEC source: 0000856982-19-000095 · wf-form4_156106935965019.xml · nonDerivative · entry 4 Karras Nolan E. · CIK 0001534914 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,000 F1 · price: The price reported in Column 4 of Table 1 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $60.815 to $60.980, inclusive. The Reporting Person undertakes to provide to Merit Medical Systems, Inc., any security holder of Merit Medical Systems, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. F2 · ownership.direct: Shares held jointly by the reporting person and his spouse. Read SEC document |
| June 19, 2019 Filed Jun 20, 2019 22:22 UTC | MERIT MEDICAL SYSTEMS INC MMSI · Entity 3858 | Exercise / conversionCommon Stock, No Par Value | 6,000 | $9.95 | $59,700.00 |
DisclosureSEC source: 0000856982-19-000095 · wf-form4_156106935965019.xml · nonDerivative · entry 3 Karras Nolan E. · CIK 0001534914 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 31, 2019 Filed Jun 4, 2019 20:44 UTC | MERIT MEDICAL SYSTEMS INC MMSI · Entity 3858 | GrantNon-qualified stock options (right to buy) · Derivative | 7,500 | $0.00 Strike: $52.17 | $0.00 |
DisclosureSEC source: 0000856982-19-000086 · wf-form4_155968106373213.xml · derivative · entry 11 Karras Nolan E. · CIK 0001534914 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,500 Underlying: Common Stock · 7,500 shares Expires 2026-05-31 F9 · derivative.exercise_date: Becomes exercisable in equal annual installments of 33% commencing 05/31/2020. Read SEC document |
| May 24, 2019 Filed May 29, 2019 23:02 UTC | MERIT MEDICAL SYSTEMS INC MMSI · Entity 3858 | GrantNon-qualified stock options (right to buy) · Derivative | 13,750 | $0.00 Strike: $52.17 | $0.00 |
DisclosureSEC source: 0000856982-19-000063 · wf-form4_155917092025067.xml · derivative · entry 10 Karras Nolan E. · CIK 0001534914 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,750 Underlying: Common Stock · 13,750 shares Expires 2026-05-24 F8 · derivative.exercise_date: Becomes exercisable in equal annual installments of 33% commencing 05/24/2020. Read SEC document |
| November 29, 2018 Filed Dec 3, 2018 21:56 UTC | MERIT MEDICAL SYSTEMS INC MMSI · Entity 3858 | Exercise / conversionNon-qualified stock options (right to buy) · Derivative | 3,000 | $0.00 Strike: $9.95 | $0.00 |
DisclosureSEC source: 0000856982-18-000090 · wf-form4_154387414669726.xml · derivative · entry 5 Karras Nolan E. · CIK 0001534914 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,000 Underlying: Common Stock · 3,000 shares Expires 2020-05-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Becomes exercisable in equal annual installments of 20% commencing 5/22/2014. Read SEC document |
| November 29, 2018 Filed Dec 3, 2018 21:56 UTC | MERIT MEDICAL SYSTEMS INC MMSI · Entity 3858 | SaleCommon Stock, No Par Value | 2,000 | $61.28 | $122,550.00 |
DisclosureSEC source: 0000856982-18-000090 · wf-form4_154387414669726.xml · nonDerivative · entry 4 Karras Nolan E. · CIK 0001534914 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,000 F2 · price: The price reported in Column 4 of Table 1 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $61.25 to $61.30, inclusive. The Reporting Person undertakes to provide to Merit Medical Systems, Inc., any security holder of Merit Medical Systems, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. F1 · ownership.direct: Shares held jointly by the reporting person and his spouse. Read SEC document |
| November 29, 2018 Filed Dec 3, 2018 21:56 UTC | MERIT MEDICAL SYSTEMS INC MMSI · Entity 3858 | Exercise / conversionCommon Stock, No Par Value | 3,000 | $9.95 | $29,850.00 |
DisclosureSEC source: 0000856982-18-000090 · wf-form4_154387414669726.xml · nonDerivative · entry 3 Karras Nolan E. · CIK 0001534914 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · ownership.direct: Shares held jointly by the reporting person and his spouse. Read SEC document |
| June 07, 2018 Filed Jun 11, 2018 22:19 UTC | MERIT MEDICAL SYSTEMS INC MMSI · Entity 3858 | GrantCommon Stock · Derivative | 25,000 | $0.00 Strike: $50.50 | $0.00 |
DisclosureSEC source: 0000856982-18-000054 · wf-form4_152875554936019.xml · derivative · entry 9 Karras Nolan E. · CIK 0001534914 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2025-06-07 F7 · derivative.exercise_date: Becomes exercisable in equal annual installments of 20% commencing 06/07/2019. Read SEC document |
| June 27, 2017 Filed Jun 29, 2017 16:26 UTC | MERIT MEDICAL SYSTEMS INC MMSI · Entity 3858 | Exercise / conversionNon-qualified stock options (right to buy) · Derivative | 8,000 | $0.00 Strike: $12.91 | $0.00 |
DisclosureSEC source: 0001179110-17-009755 · edgar.xml · derivative · entry 5 Karras Nolan E. · CIK 0001534914 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 8,000 shares Expires 2019-05-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Becomes exercisable in equal annual installments of 20% commencing 5/23/2013. Read SEC document |
| June 27, 2017 Filed Jun 29, 2017 16:26 UTC | MERIT MEDICAL SYSTEMS INC MMSI · Entity 3858 | SaleCommon Stock, No Par Value | 7,000 | $37.15 | $260,057.00 |
DisclosureSEC source: 0001179110-17-009755 · edgar.xml · nonDerivative · entry 4 Karras Nolan E. · CIK 0001534914 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,000 F1 · price: The price reported in Column 4 of Table 1 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $37.150 to 37.155, inclusive. The reporting person undertakes to provide to Merit Medical Systems, Inc., any security holder of Merit Medical Systems, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. F2 · ownership.direct: Shares held jointly by the reporting person and his spouse. Read SEC document |
| June 27, 2017 Filed Jun 29, 2017 16:26 UTC | MERIT MEDICAL SYSTEMS INC MMSI · Entity 3858 | Exercise / conversionCommon Stock, No Par Value | 8,000 | $12.91 | $103,280.00 |
DisclosureSEC source: 0001179110-17-009755 · edgar.xml · nonDerivative · entry 3 Karras Nolan E. · CIK 0001534914 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 24, 2017 Filed May 26, 2017 20:47 UTC | MERIT MEDICAL SYSTEMS INC MMSI · Entity 3858 | GrantNon-qualified stock options (right to buy) · Derivative | 25,000 | $0.00 Strike: $34.40 | $0.00 |
DisclosureSEC source: 0001179110-17-008136 · edgar.xml · derivative · entry 8 Karras Nolan E. · CIK 0001534914 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2024-05-24 F6 · derivative.exercise_date: Becomes exercisable in equal annual installments of 20% commencing 5/24/2018. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.